| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.00065 | 1 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.00051 | 1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.00043 | 1 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.00048 | 1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.00059 | 1 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.00046 | 1 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.00094 | 1 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.00034 | 1 |